Vertex Pharmaceuticals Inc / Ma

Independent Advisor Alliance VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/4/2026

Shares

3,300

Value ($000)

1,496

Weight

0.0%

2020 Q1 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/4/2026	1,496	0.0%	3,300	12/31/2025
2025 Q3	11/4/2025	1,263	0.0%	3,226	9/30/2025
2025 Q2	8/11/2025	1,295	0.0%	2,909	6/30/2025
2025 Q1	5/12/2025	1,371	0.0%	2,828	3/31/2025
2024 Q4	2/7/2025	897	0.0%	2,228	12/31/2024
2024 Q3	11/13/2024	546	0.0%	1,174	9/30/2024
2024 Q2	8/12/2024	850	0.0%	1,813	6/30/2024
2024 Q1	5/8/2024	578	0.0%	1,383	3/31/2024
2023 Q4	2/8/2024	575	0.0%	1,412	12/31/2023
2023 Q3	10/24/2023	463	0.0%	1,332	9/30/2023
2023 Q2	7/28/2023	472	0.0%	1,342	6/30/2023
2023 Q1	5/12/2023	379	0.0%	1,203	3/31/2023
2022 Q3	11/4/2022	346	0.0%	1,195	9/30/2022
2022 Q2	8/4/2022	428	0.0%	1,520	6/30/2022
2022 Q1	5/6/2022	497	0.0%	1,906	3/31/2022
2021 Q2	8/12/2021	239	0.0%	1,187	6/30/2021
2021 Q1	5/14/2021	243	0.0%	1,130	3/31/2021
2020 Q4	2/11/2021	255	0.0%	1,081	12/31/2020
2020 Q3	11/4/2020	308	0.0%	1,131	9/30/2020
2020 Q2	8/6/2020	3,355	0.4%	11,555	6/30/2020
2020 Q1	5/14/2020	257	0.0%	1,081	3/31/2020